Magnetar Financial’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Magnetar Financial’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,305,772	Closed	-$9.82M	–	1510
2022 Q2	$9.82M	Buy	1,305,772 +786,858	+152%	+$6.86M	0.1%	188
2022 Q1	$4.87M	Buy	518,914 +15,471	+3%	+$129K	0.05%	363
2021 Q4	$4.03M	Buy	+503,443	New	+$4.54M	0.04%	453
2019 Q4	–	Sell	-449,778	Closed	-$3.09M	–	644
2019 Q3	$3.09M	Sell	449,778 -57,122	-11%	-$438K	0.08%	130
2019 Q2	$4.68M	Buy	506,900 +218,900	+76%	+$2.64M	0.09%	95
2019 Q1	$4.52M	Sell	288,000 -287,001	-50%	-$5.06M	0.12%	80
2018 Q4	$8.87M	Buy	575,001 +255,000	+80%	+$5.23M	0.22%	57
2018 Q3	$6.89M	Buy	+320,001	New	+$7.43M	0.12%	74

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Magnetar Financial's TEVA Position: Q3 2022 in Review

Magnetar Financial sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2022, closing a stake of 1,305,772 shares — an estimated $9.82M sold.

Magnetar Financial first reported a position in TEVA in Q3 2018 and held it in 8 quarters. The position peaked at $9.82M in Q2 2022. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

Magnetar Financial reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2022 after selling out during the quarter.
Magnetar Financial sold 1,305,772 Teva Pharmaceutical Industries Limited shares in Q3 2022, an estimated $9.82M.
Magnetar Financial first reported a position in Teva Pharmaceutical Industries Limited in Q3 2018 and held it in 8 quarters.
Magnetar Financial's Teva Pharmaceutical Industries Limited position peaked at $9.82M in Q2 2022.
430 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2022.

Based on Magnetar Financial's 13F filing for Q3 2022, filed 14 Nov 2022.